{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T02:59:04Z","timestamp":1770433144843,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fundaci\u00f3n Argentina de Infectolog\u00eda Pedi\u00e1trica","award":["Fundaci\u00f3n Argentina de Infectolog\u00eda Pedi\u00e1trica"],"award-info":[{"award-number":["Fundaci\u00f3n Argentina de Infectolog\u00eda Pedi\u00e1trica"]}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas"],"award-info":[{"award-number":["Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promoci\u00f3n de la Investigaci\u00f3n, el Desarrollo Tecnol\u00f3gico y la Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IP-COVID-19-406"],"award-info":[{"award-number":["IP-COVID-19-406"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health of the Autonomous City of Buenos Aires","award":["1330\/MSGC\/21"],"award-info":[{"award-number":["1330\/MSGC\/21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00284-025-04627-x","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T07:44:19Z","timestamp":1765266259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Persistence of SARS-CoV-2\u00a0S IgG Antibodies in Children Post-COVID-19 and the Association of Antibody Levels with Vaccination Status"],"prefix":"10.1007","volume":"83","author":[{"given":"Eduardo L.","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5616-6438","authenticated-orcid":false,"given":"Mar\u00eda S.","family":"Tineo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Di Gregorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3646-5749","authenticated-orcid":false,"given":"Mar\u00eda F.","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8991-8672","authenticated-orcid":false,"given":"Florencia A.","family":"Bonnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia E.","family":"Torrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola J.","family":"Karp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6077-3922","authenticated-orcid":false,"given":"Anal\u00eda","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0076-5903","authenticated-orcid":false,"given":"Ana","family":"Caratozzolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4501-7052","authenticated-orcid":false,"given":"Sergio I.","family":"Nemirovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda M.","family":"Contrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9393-2004","authenticated-orcid":false,"given":"Lorena I.","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2635-474X","authenticated-orcid":false,"given":"Laura B.","family":"Talarico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"4627_CR1","unstructured":"World Health Organization Coronavirus (COVID-19) Dashboard. https:\/\/data.who.int\/dashboards\/covid19\/cases?n=o"},{"key":"4627_CR2","doi-asserted-by":"publisher","first-page":"631139","DOI":"10.3389\/fimmu.2021.631139","volume":"12","author":"CR Triggle","year":"2021","unstructured":"Triggle CR, Bansal D, Ding H, Islam MM, Farag E, Hadi HA, Sultan AA (2021) A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic. Front Immunol 12:631139. https:\/\/doi.org\/10.3389\/fimmu.2021.631139","journal-title":"Front Immunol"},{"key":"4627_CR3","doi-asserted-by":"publisher","first-page":"1159326","DOI":"10.3389\/fimmu.2023.1159326","volume":"14","author":"J Shen","year":"2023","unstructured":"Shen J, Fan J, Zhao Y, Jiang D, Niu Z, Zhang Z, Cao G (2023) Innate and adaptive immunity to SARS-CoV-2 and predisposing factors. Front Immunol 14:1159326. https:\/\/doi.org\/10.3389\/fimmu.2023.1159326","journal-title":"Front Immunol"},{"issue":"16","key":"4627_CR4","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jama.2020.5394","volume":"323","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A, Network C-LI (2020) Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 323(16):1574\u20131581. https:\/\/doi.org\/10.1001\/jama.2020.5394","journal-title":"JAMA"},{"issue":"2","key":"4627_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41390-023-02549-7","volume":"94","author":"GA Rotulo","year":"2023","unstructured":"Rotulo GA, Palma P (2023) Understanding COVID-19 in children: immune determinants and post-infection conditions. Pediatr Res 94(2):434\u2013442. https:\/\/doi.org\/10.1038\/s41390-023-02549-7","journal-title":"Pediatr Res"},{"issue":"17","key":"4627_CR6","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMc2005073","volume":"382","author":"X Lu","year":"2020","unstructured":"Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Zhang W, Wang Y, Bao S, Li Y, Wu C, Liu H, Liu D, Shao J, Peng X, Yang Y, Liu Z, Xiang Y, Zhang F, Silva RM, Pinkerton KE, Shen K, Xiao H, Xu S, Wong GWK, Chinese Pediatric Novel Coronavirus Study T (2020) SARS-CoV-2 infection in children. N Engl J Med 382(17):1663\u20131665. https:\/\/doi.org\/10.1056\/NEJMc2005073","journal-title":"N Engl J Med"},{"issue":"6","key":"4627_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/apa.15271","volume":"109","author":"P Brodin","year":"2020","unstructured":"Brodin P (2020) Why is COVID-19 so mild in children? Acta Paediatr 109(6):1082\u20131083. https:\/\/doi.org\/10.1111\/apa.15271","journal-title":"Acta Paediatr"},{"issue":"1","key":"4627_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson CB, Farzan M, Chen B, Choe H (2022) Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 23(1):3\u201320. https:\/\/doi.org\/10.1038\/s41580-021-00418-x","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"4627_CR9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41590-022-01248-5","volume":"23","author":"H Qi","year":"2022","unstructured":"Qi H, Liu B, Wang X, Zhang L (2022) The humoral response and antibodies against SARS-CoV-2 infection. Nat Immunol 23(7):1008\u20131020. https:\/\/doi.org\/10.1038\/s41590-022-01248-5","journal-title":"Nat Immunol"},{"issue":"8","key":"4627_CR10","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","volume":"26","author":"QX Long","year":"2020","unstructured":"Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, Hu JL, Xu W, Zhang Y, Lv FJ, Su K, Zhang F, Gong J, Wu B, Liu XM, Li JJ, Qiu JF, Chen J, Huang AL (2020) Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 26(8):1200\u20131204. https:\/\/doi.org\/10.1038\/s41591-020-0965-6","journal-title":"Nat Med"},{"key":"4627_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4063","author":"JM Dan","year":"2021","unstructured":"Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, Grifoni A, Ramirez SI, Haupt S, Frazier A, Nakao C, Rayaprolu V, Rawlings SA, Peters B, Krammer F, Simon V, Saphire EO, Smith DM, Weiskopf D, Sette A, Crotty S (2021) Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. https:\/\/doi.org\/10.1126\/science.abf4063","journal-title":"Science"},{"issue":"11","key":"4627_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/INF.0000000000003669","volume":"41","author":"LB Talarico","year":"2022","unstructured":"Talarico LB, Toledano A, Contrini MM, Torrado LE, Martinez MP, Gaillard MI, Caratozzolo A, Byrne AB, Bonnin FA, Tineo MS, Yfran EW, Acosta PL, Lopez EL (2022) Distinct immune phenotypes and cytokine profiles in children with differing severity of COVID-19. Pediatr Infect Dis J 41(11):919\u2013926. https:\/\/doi.org\/10.1097\/INF.0000000000003669","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"4627_CR13","doi-asserted-by":"publisher","first-page":"e221313","DOI":"10.1001\/jamanetworkopen.2022.1313","volume":"5","author":"ZQ Toh","year":"2022","unstructured":"Toh ZQ, Anderson J, Mazarakis N, Neeland M, Higgins RA, Rautenbacher K, Dohle K, Nguyen J, Overmars I, Donato C, Sarkar S, Clifford V, Daley A, Nicholson S, Mordant FL, Subbarao K, Burgner DP, Curtis N, Bines JE, McNab S, Steer AC, Mulholland K, Tosif S, Crawford NW, Pellicci DG, Do LAH, Licciardi PV (2022) Comparison of seroconversion in children and adults with mild COVID-19. JAMA Netw Open 5(3):e221313. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.1313","journal-title":"JAMA Netw Open"},{"issue":"7","key":"4627_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.21616","volume":"5","author":"C Di Chiara","year":"2022","unstructured":"Di Chiara C, Cantarutti A, Costenaro P, Dona D, Bonfante F, Cosma C, Ferrarese M, Cozzani S, Petrara MR, Carmona F, Liberati C, Palma P, Di Salvo G, De Rossi A, Plebani M, Padoan A, Giaquinto C (2022) Long-term immune response to SARS-CoV-2 infection among children and adults after mild infection. JAMA Netw Open 5(7):e2221616. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.21616","journal-title":"JAMA Netw Open"},{"issue":"11","key":"4627_CR15","doi-asserted-by":"publisher","first-page":"e041661","DOI":"10.1136\/bmjopen-2020-041661","volume":"10","author":"M Corr","year":"2020","unstructured":"Corr M, Christie S, Watson C, Maney J, Fairley D, Ladhani SN, Lyttle MD, McFetridge L, Mitchell H, Shields MD, McGinn C, McKenna J, Mallett P, Ferris K, Rowe-Setz G, Moore R, Foster S, Evans J, Waterfield T (2020) Seroprevalence of SARS-CoV-2 antibodies in children of united Kingdom healthcare workers: a prospective multicentre cohort study protocol. BMJ Open 10(11):e041661. https:\/\/doi.org\/10.1136\/bmjopen-2020-041661","journal-title":"BMJ Open"},{"key":"4627_CR16","doi-asserted-by":"publisher","first-page":"961198","DOI":"10.3389\/fimmu.2022.961198","volume":"13","author":"VP Chavda","year":"2022","unstructured":"Chavda VP, Yao Q, Vora LK, Apostolopoulos V, Patel CA, Bezbaruah R, Patel AB, Chen ZS (2022) Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world. Front Immunol 13:961198. https:\/\/doi.org\/10.3389\/fimmu.2022.961198","journal-title":"Front Immunol"},{"key":"4627_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030421","author":"P Gao","year":"2022","unstructured":"Gao P, Cai S, Liu Q, Du M, Liu J, Liu M (2022) Effectiveness and safety of SARS-CoV-2 vaccines among children and adolescents: a systematic review and meta-analysis. Vaccines. https:\/\/doi.org\/10.3390\/vaccines10030421","journal-title":"Vaccines"},{"key":"4627_CR18","unstructured":"Actualizaci\u00f3n de los Lineamientos T\u00e9cnicos. Resumen de recomendaciones vigentes Para La Campa\u00f1a Nacional de Vacunaci\u00f3n contra La COVID-19 (2022)  Ministerio de Salud, Argentina https:\/\/www.argentina.gob.ar\/sites\/default\/files\/bancos\/2022-02\/lineamientos-tecnicos_unificado-covid19-2022.pdf"},{"issue":"8","key":"4627_CR19","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"JC Marshall","year":"2020","unstructured":"Marshall JC, Murthy S, Diaz J et al (2020) A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 20(8):e192\u2013e197. https:\/\/doi.org\/10.1016\/S1473-3099(20)30483-7","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"4627_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/PCC.0000000000003331","volume":"24","author":"SB Leland","year":"2023","unstructured":"Leland SB, Staffa SJ, Newhams MM et al (2023) The modified clinical progression scale for pediatric patients: evaluation as a severity metric and outcome measure in severe acute viral respiratory illness. Pediatr Crit Care Med 24(12):998\u20131009. https:\/\/doi.org\/10.1097\/PCC.0000000000003331","journal-title":"Pediatr Crit Care Med"},{"key":"4627_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/v16020185","author":"MF Pavan","year":"2024","unstructured":"Pavan MF, Bok M, Betanzos San Juan R, Malito JP, Marcoppido GA, Franco DR, Militelo DA, Schammas JM, Bari SE, Stone W, Lopez K, Porier DL, Muller JA, Auguste AJ, Yuan L, Wigdorovitz A, Parreno VG, Ibanez LI (2024) SARS-CoV-2 specific nanobodies neutralize different variants of concern and reduce virus load in the brain of h-ACE2 transgenic mice. Viruses. https:\/\/doi.org\/10.3390\/v16020185","journal-title":"Viruses"},{"key":"4627_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/mps1010008","author":"F Ferrara","year":"2018","unstructured":"Ferrara F, Temperton N (2018) Pseudotype neutralization assays: from laboratory bench to data analysis. Methods Protoc. https:\/\/doi.org\/10.3390\/mps1010008","journal-title":"Methods Protoc"},{"key":"4627_CR23","unstructured":"Actualizaci\u00f3n de los Lineamientos T\u00e9cnicos Campa\u00f1a Nacional de Vacunaci\u00f3n contra la COVID-19. Octubre 2021. Ministerio de Salud, Argentina. https:\/\/www.argentina.gob.ar\/sites\/default\/files\/bancos\/2021-10\/LT%20COVID-19%20unificado%20Octubre.pdf"},{"key":"4627_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10060700","author":"A Mendez-Echevarria","year":"2021","unstructured":"Mendez-Echevarria A, Sainz T, Falces-Romero I, de Felipe B, Escolano L, Alcolea S, Pertinez L, Neth O, Calvo C (2021) Long-term persistence of anti-SARS-CoV-2 antibodies in a pediatric population. Pathogens. https:\/\/doi.org\/10.3390\/pathogens10060700","journal-title":"Pathogens"},{"issue":"8","key":"4627_CR25","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3201\/eid2708.210965","volume":"27","author":"ZQ Toh","year":"2021","unstructured":"Toh ZQ, Higgins RA, Do LAH, Rautenbacher K, Mordant FL, Subbarao K, Dohle K, Nguyen J, Steer AC, Tosif S, Crawford NW, Mulholland K, Licciardi PV (2021) Persistence of SARS-CoV-2-specific IgG in children 6 months after infection, Australia. Emerg Infect Dis 27(8):2233\u20132235. https:\/\/doi.org\/10.3201\/eid2708.210965","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"4627_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00284-022-02800-0","volume":"79","author":"Z Yousefi","year":"2022","unstructured":"Yousefi Z, Taheri N, Dargahi M, Chaman R, Binesh E, Emamian MH, Jafari R (2022) Long-term persistence of anti-SARS-COV-2 IgG antibodies. Curr Microbiol 79(4):96. https:\/\/doi.org\/10.1007\/s00284-022-02800-0","journal-title":"Curr Microbiol"},{"issue":"8","key":"4627_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264667","volume":"17","author":"M Sarjomaa","year":"2022","unstructured":"Sarjomaa M, Diep LM, Zhang C, Tveten Y, Reiso H, Thilesen C, Nordbo SA, Berg KK, Aaberge I, Pearce N, Kersten H, Vandenbroucke JP, Eikeland R, Fell AKM (2022) SARS-CoV-2 antibody persistence after five and twelve months: a cohort study from South-Eastern Norway. PLoS One 17(8):e0264667. https:\/\/doi.org\/10.1371\/journal.pone.0264667","journal-title":"PLoS One"},{"issue":"11","key":"4627_CR28","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1007\/s00431-021-04124-w","volume":"180","author":"S Bloise","year":"2021","unstructured":"Bloise S, Marcellino A, Testa A, Dilillo A, Mallardo S, Isoldi S, Martucci V, Sanseviero MT, Del Giudice E, Iorfida D, Ventriglia F, Lubrano R (2021) Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults. Eur J Pediatr 180(11):3335\u20133342. https:\/\/doi.org\/10.1007\/s00431-021-04124-w","journal-title":"Eur J Pediatr"},{"issue":"6","key":"4627_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/jpids\/piac012","volume":"11","author":"MS Han","year":"2022","unstructured":"Han MS, Um J, Lee EJ, Kim KM, Chang SH, Lee H, Kim YK, Choi YY, Cho EY, Kim DH, Choi JH, Lee J, Kim M, Chung KH, Min HS, Choe YJ, Lim DG, Park JS, Choi EH (2022) Antibody responses to SARS-CoV-2 in children with COVID-19. J Pediatr Infect Dis Soc 11(6):267\u2013273. https:\/\/doi.org\/10.1093\/jpids\/piac012","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"2","key":"4627_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41423-020-00588-2","volume":"18","author":"V Legros","year":"2021","unstructured":"Legros V, Denolly S, Vogrig M, Boson B, Siret E, Rigaill J, Pillet S, Grattard F, Gonzalo S, Verhoeven P, Allatif O, Berthelot P, Pelissier C, Thiery G, Botelho-Nevers E, Millet G, Morel J, Paul S, Walzer T, Cosset FL, Bourlet T, Pozzetto B (2021) A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity. Cell Mol Immunol 18(2):318\u2013327. https:\/\/doi.org\/10.1038\/s41423-020-00588-2","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"4627_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac554","volume":"9","author":"L Tomasi","year":"2022","unstructured":"Tomasi L, Thiriard A, Heyndrickx L, Georges D, den Van Wijngaert S, Olislagers V, Sharma S, Matagne A, Ackerman ME, Arien KK, Goetghebuer T, Marchant A (2022) Younger children develop higher effector antibody responses to SARS-CoV-2 infection. Open Forum Infect Dis 9(11):ofac554. https:\/\/doi.org\/10.1093\/ofid\/ofac554","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"4627_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01333-24","volume":"13","author":"A Nouanesengsy","year":"2025","unstructured":"Nouanesengsy A, Semesi A, Quach K, Ivanochko D, Byrne W, Hwang M, La Neve MR, Leon-Ponte M, Litosh A, Wisener N, Adeli K, Campigotto A, Grunebaum E, McGeer A, Moraes TJ, Sepiashvili L, Upton J, Julien JP, Allen U (2025) Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort. Microbiol Spectr e0133324. https:\/\/doi.org\/10.1128\/spectrum.01333-24","journal-title":"Microbiol Spectr"},{"issue":"1","key":"4627_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2184176","volume":"12","author":"R Bingula","year":"2023","unstructured":"Bingula R, Chabrolles H, Bonnet B, Archimbaud C, Brebion A, Cosme J, Ollier A, Dutheil F, Junda M, Mirand A, Regagnon C, Vidal M, Henquell C, Evrard B (2023) Increase over time of antibody levels 3 months after a booster dose as an indication of better protection against Omicron infection. Emerg Microbes Infect 12(1):2184176. https:\/\/doi.org\/10.1080\/22221751.2023.2184176","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"4627_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jinf.2022.04.018","volume":"84","author":"X Liu","year":"2022","unstructured":"Liu X, Munro APS, Feng S, Janani L, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dejnirattisai W, Dodd K, Enever Y, Qureshi E, Goodman AL, Green CA, Harndahl L, Haughney J, Hicks A, van der Klaauw AA, Kwok J, Libri V, Llewelyn MJ, McGregor AC, Minassian AM, Moore P, Mughal M, Mujadidi YF, Holliday K, Osanlou O, Osanlou R, Owens DR, Pacurar M, Palfreeman A, Pan D, Rampling T, Regan K, Saich S, Serafimova T, Saralaya D, Screaton GR, Sharma S, Sheridan R, Sturdy A, Supasa P, Thomson EC, Todd S, Twelves C, Read RC, Charlton S, Hallis B, Ramsay M, Andrews N, Lambe T, Nguyen-Van-Tam JS, Cornelius V, Snape MD, group C-Bs (2022) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial. J Infect 84(6):795\u2013813. https:\/\/doi.org\/10.1016\/j.jinf.2022.04.018","journal-title":"J Infect"},{"issue":"1","key":"4627_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5114\/ceji.2023.125239","volume":"48","author":"L Bozic","year":"2023","unstructured":"Bozic L, Knezevic D, Travar M, Miljus N, Petkovic M, Acimovic J, Devic JD, Stojiljkovic MP, Bokonjic D, Skrbic R (2023) The comparison of SARS-CoV-2 antibody levels in medical personnel induced by different types of vaccines compared to the natural infection. Cent Eur J Immunol 48(1):35\u201342. https:\/\/doi.org\/10.5114\/ceji.2023.125239","journal-title":"Cent Eur J Immunol"},{"issue":"1","key":"4627_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12879-025-10621-2","volume":"25","author":"I Guzel","year":"2025","unstructured":"Guzel I, Ozturk G, Appak O, Caglayan D, Suner AF, Irmak C, Ture N, Isik E, Celik M, Ergor G, Ergor A, Demiral Y, Alp Cavus S, Kilic B, Sayiner A (2025) Neutralizing and binding antibody dynamics following primary and booster COVID-19 vaccination among healthcare workers. BMC Infect Dis 25(1):218. https:\/\/doi.org\/10.1186\/s12879-025-10621-2","journal-title":"BMC Infect Dis"},{"issue":"12","key":"4627_CR37","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3201\/eid2612.203334","volume":"26","author":"WT Hu","year":"2020","unstructured":"Hu WT, Howell JC, Ozturk T, Benameur K, Bassit LC, Ramonell R, Cashman KS, Pirmohammed S, Roback JD, Marconi VC, Yang I, Mac VV, Smith D, Sanz I, Wharton W, Lee FE, Schinazi RF (2020) Antibody profiles according to mild or severe SARS-CoV-2 infection, Atlanta, Georgia, USA, 2020. Emerg Infect Dis 26(12):2974\u20132978. https:\/\/doi.org\/10.3201\/eid2612.203334","journal-title":"Emerg Infect Dis"},{"issue":"6 Pt 1","key":"4627_CR38","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jmii.2022.04.005","volume":"55","author":"JH Park","year":"2022","unstructured":"Park JH, Cha MJ, Choi H, Kim MC, Chung JW, Lee KS, Jeong DG, Baek MS, Kim WY, Lim Y, Yoon SW, Choi SH (2022) Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19. J Microbiol Immunol Infect 55(6 Pt 1):1094\u20131100. https:\/\/doi.org\/10.1016\/j.jmii.2022.04.005","journal-title":"J Microbiol Immunol Infect"},{"key":"4627_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103615","volume":"72","author":"I Sananez","year":"2021","unstructured":"Sananez I, Raiden SC, Algieri SC, Uranga M, Grisolia NA, Filippo D, De Carli N, Lalla SD, Cairoli H, Chiolo MJ, Meregalli CN, Cohen E, Mosquera G, Marco Del Pont M, Gimenez LI, Gregorio G, Sarli M, Alcalde AL, Davenport C, Bruera MJ, Simaz N, Perez MF, Nivela V, Bayle C, Alvarez L, Revetria M, Tuccillo P, Agosta MT, Perez H, Nova SV, Suarez P, Takata EM, Garcia M, Lattner J, Rolon MJ, Coll P, Salvatori M, Piccardo C, Russo C, Varese A, Seery V, Holgado MP, Polo ML, Ceballos A, Nunez M, Penedo JMG, Ferrero F, Geffner J, Arruvito L (2021) A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children. EBioMedicine 72:103615. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103615","journal-title":"EBioMedicine"},{"key":"4627_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104230","volume":"83","author":"V Seery","year":"2022","unstructured":"Seery V, Raiden S, Russo C, Borda M, Herrera L, Uranga M, Varese A, Marco Del Pont M, Chirino C, Erramuspe C, Alvarez LS, Lenoir M, Morales LD, Davenport C, Alarcon Flores A, Huespe Auchter S, Ruiz Y, Monsalvo L, Sastoque L, Gavazzi M, Mazzitelli I, Di Diego F, Longueira Y, Mazzitelli B, Sananez I, De Carli N, Biglione MM, Gomez Penedo JM, Ceballos A, Laufer N, Ferrero F, Geffner J, Arruvito L (2022) Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: an observational cohort study. EBioMedicine 83:104230. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104230","journal-title":"EBioMedicine"},{"issue":"1","key":"4627_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12985-023-02056-5","volume":"20","author":"CF Huang","year":"2023","unstructured":"Huang CF, Jang TY, Wu PH, Kuo MC, Yeh ML, Wang CW, Liang PC, Wei YJ, Hsu PY, Huang CI, Hsieh MY, Lin YH, Hsiao HH, Hsu CM, Huang CT, Lee CY, Chen YH, Chen TC, Lin KD, Wang SH, Wang SF, Huang JF, Dai CY, Chuang WL, Yu ML (2023) Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort. Virol J 20(1):112. https:\/\/doi.org\/10.1186\/s12985-023-02056-5","journal-title":"Virol J"},{"issue":"1","key":"4627_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-022-00271-2","volume":"19","author":"X Jing","year":"2022","unstructured":"Jing X, Xu M, Song D, Yue T, Wang Y, Zhang P, Zhong Y, Zhang M, Lam TT, Faria NR, De Clercq E, Li G (2022) Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19. Immun Ageing 19(1):12. https:\/\/doi.org\/10.1186\/s12979-022-00271-2","journal-title":"Immun Ageing"},{"key":"4627_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1543626","volume":"16","author":"S Castro-Trujillo","year":"2025","unstructured":"Castro-Trujillo S, Castro-Meneses J, Rojas MC, Castro-Amaya M, Lastra G, Narvaez CF (2025) Regulatory cytokines modulate early isotype-specific response associated with COVID-19 survival. Front Immunol 16:1543626. https:\/\/doi.org\/10.3389\/fimmu.2025.1543626","journal-title":"Front Immunol"},{"key":"4627_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.842468","volume":"13","author":"MJ Ruiz","year":"2022","unstructured":"Ruiz MJ, Siracusano G, Cottignies-Calamarte A, Tudor D, Real F, Zhu A, Pastori C, Capron C, Rosenberg AR, Temperton N, Cantoni D, Liao H, Ternette N, Moine P, Godement M, Geri G, Chiche JD, Annane D, Cramer Borde E, Lopalco L, Bomsel M (2022) Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1\u03b2 associate with COVID-19 fatal outcome: a cross-sectional analysis. Front Immunol 13:842468. https:\/\/doi.org\/10.3389\/fimmu.2022.842468","journal-title":"Front Immunol"},{"key":"4627_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1505719","volume":"15","author":"LH Kuijper","year":"2024","unstructured":"Kuijper LH, Kreher C, Elias G, Claireaux M, Kerster G, Bos AV, Duurland MC, Konijn VAL, Paul AGA, de Jong N, de Jongh R, Steenhuis M, Garcia-Vallejo JJ, van Gils MJ, Kuijpers TW, Eftimov F, Rispens T, van der Schoot CE, van Ham SM, Ten Brinke A (2024) Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection. Front Immunol 15:1505719. https:\/\/doi.org\/10.3389\/fimmu.2024.1505719","journal-title":"Front Immunol"},{"issue":"6","key":"4627_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02419-23","volume":"11","author":"M Masia","year":"2023","unstructured":"Masia M, de la Rica A, Fernandez-Gonzalez M, Garcia JA, Padilla S, Garcia-Abellan J, Botella A, Mascarell P, Gutierrez F (2023) Integrating SARS-CoV-2-specific interferon-\u03b3 release assay testing in the evaluation of patients hospitalized with COVID-19. Microbiol Spectr 11(6):e0241923. https:\/\/doi.org\/10.1128\/spectrum.02419-23","journal-title":"Microbiol Spectr"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-025-04627-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:14:17Z","timestamp":1770383657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-025-04627-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4627"],"URL":"https:\/\/doi.org\/10.1007\/s00284-025-04627-x","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Review Board of Ricardo Gutierrez Children\u2019s Hospital, ensuring compliance with the ethical principles of Helsinki Declaration for clinical research. Informed consent from father, mother or legal guardian of all pediatric participants, assent if applicable, and adult consent were obtained before performing any procedure related to the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"61"}}